These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25998745)

  • 1. Daintain/AIF-1 accelerates the activation of insulin-like growth factor-1 receptor signaling pathway in HepG2 cells.
    Jia S; Du Z; Jiang H; Huang X; Chen Z; Chen N
    Oncol Rep; 2015 Jul; 34(1):511-7. PubMed ID: 25998745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pleiotropic effect of the single clustered hepatic metastamiRs miR-96-5p and miR-182-5p on insulin-like growth factor II, insulin-like growth factor-1 receptor and insulin-like growth factor-binding protein-3 in hepatocellular carcinoma.
    Assal RA; El Tayebi HM; Hosny KA; Esmat G; Abdelaziz AI
    Mol Med Rep; 2015 Jul; 12(1):645-50. PubMed ID: 25739014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage.
    Tovar V; Alsinet C; Villanueva A; Hoshida Y; Chiang DY; Solé M; Thung S; Moyano S; Toffanin S; Mínguez B; Cabellos L; Peix J; Schwartz M; Mazzaferro V; Bruix J; Llovet JM
    J Hepatol; 2010 Apr; 52(4):550-9. PubMed ID: 20206398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daintain/AIF-1 promotes breast cancer proliferation via activation of the NF-kappaB/cyclin D1 pathway and facilitates tumor growth.
    Liu S; Tan WY; Chen QR; Chen XP; Fu K; Zhao YY; Chen ZW
    Cancer Sci; 2008 May; 99(5):952-7. PubMed ID: 18341653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daintain/AIF-1 promotes breast cancer cell migration by up-regulated TNF-α via activate p38 MAPK signaling pathway.
    Li T; Feng Z; Jia S; Wang W; Du Z; Chen N; Chen Z
    Breast Cancer Res Treat; 2012 Feb; 131(3):891-8. PubMed ID: 21509525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation.
    Huynh H; Chow PK; Ooi LL; Soo KC
    Cell Growth Differ; 2002 Mar; 13(3):115-22. PubMed ID: 11959812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression.
    Yin J; Ding J; Huang L; Tian X; Shi X; Zhi L; Song J; Zhang Y; Gao X; Yao Z; Jing X; Yang J
    Anat Rec (Hoboken); 2013 Oct; 296(10):1568-75. PubMed ID: 23878061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor-binding protein-3 inhibits IGF-1-induced proliferation of human hepatocellular carcinoma cells by controlling bFGF and PDGF autocrine/paracrine loops.
    Ma Y; Han CC; Li Y; Wang Y; Wei W
    Biochem Biophys Res Commun; 2016 Sep; 478(2):964-9. PubMed ID: 27521890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Abnormal expression of insulin-like growth factor-II and intervening of its mRNA transcription in the promotion of HepG2 cell apoptosis].
    Dong ZZ; Yao M; Qian J; Yan XD; Chen J; Yan MJ; Yao NH; Yao DF
    Zhonghua Yi Xue Za Zhi; 2013 Mar; 93(12):892-6. PubMed ID: 23863671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGCG inhibits activation of the insulin-like growth factor (IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells.
    Shimizu M; Shirakami Y; Sakai H; Tatebe H; Nakagawa T; Hara Y; Weinstein IB; Moriwaki H
    Cancer Lett; 2008 Apr; 262(1):10-8. PubMed ID: 18164805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum from Chronic Hepatitis B Patients Promotes Growth and Proliferation via the IGF-II/IGF-IR/MEK/ERK Signaling Pathway in Hepatocellular Carcinoma Cells.
    Ji Y; Wang Z; Chen H; Zhang L; Zhuo F; Yang Q
    Cell Physiol Biochem; 2018; 47(1):39-53. PubMed ID: 29763915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma.
    Law PT; Ching AK; Chan AW; Wong QW; Wong CK; To KF; Wong N
    Carcinogenesis; 2012 Jun; 33(6):1134-41. PubMed ID: 22431718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of IGF-1R/EGFR cross-talks on hepatoma cell sensitivity to gefitinib.
    Desbois-Mouthon C; Cacheux W; Blivet-Van Eggelpoël MJ; Barbu V; Fartoux L; Poupon R; Housset C; Rosmorduc O
    Int J Cancer; 2006 Dec; 119(11):2557-66. PubMed ID: 16988945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of insulin-like growth factor binding protein-3 is correlated with lower portal invasion and better prognosis in human hepatocellular carcinoma.
    Aishima S; Basaki Y; Oda Y; Kuroda Y; Nishihara Y; Taguchi K; Taketomi A; Maehara Y; Hosoi F; Maruyama Y; Fotovati A; Oie S; Ono M; Ueno T; Sata M; Yano H; Kojiro M; Kuwano M; Tsuneyoshi M
    Cancer Sci; 2006 Nov; 97(11):1182-90. PubMed ID: 16965600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GRK2 negatively regulates IGF-1R signaling pathway and cyclins' expression in HepG2 cells.
    Wei Z; Hurtt R; Gu T; Bodzin AS; Koch WJ; Doria C
    J Cell Physiol; 2013 Sep; 228(9):1897-901. PubMed ID: 23460259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autocrine insulin-like growth factor-II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesis.
    Nussbaum T; Samarin J; Ehemann V; Bissinger M; Ryschich E; Khamidjanov A; Yu X; Gretz N; Schirmacher P; Breuhahn K
    Hepatology; 2008 Jul; 48(1):146-56. PubMed ID: 18537183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms.
    Cantarini MC; de la Monte SM; Pang M; Tong M; D'Errico A; Trevisani F; Wands JR
    Hepatology; 2006 Aug; 44(2):446-57. PubMed ID: 16871543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor binding protein-1 inhibits cancer cell invasion and is associated with poor prognosis in hepatocellular carcinoma.
    Dai B; Ruan B; Wu J; Wang J; Shang R; Sun W; Li X; Dou K; Wang D; Li Y
    Int J Clin Exp Pathol; 2014; 7(9):5645-54. PubMed ID: 25337205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor/HER3/AKT signaling pathway: rational basis for cotargeting insulin-like growth factor-1 receptor and epidermal growth factor receptor in hepatocellular carcinoma.
    Desbois-Mouthon C; Baron A; Blivet-Van Eggelpoël MJ; Fartoux L; Venot C; Bladt F; Housset C; Rosmorduc O
    Clin Cancer Res; 2009 Sep; 15(17):5445-56. PubMed ID: 19706799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of hepatocellular carcinoma cell growth by an anti-insulin-like growth factor-I receptor monoclonal antibody.
    Yue L; Wang Y; Wang H; Gao H; Liang J; Sui A; Xiang J; Zhou F; Xu C; Zhao W; Liang W; Yao R
    Oncol Rep; 2012 Oct; 28(4):1453-60. PubMed ID: 22895605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.